Inspire Medical Systems, Inc. (INSP)
63.08
+0.94
(+1.51%)
USD |
NYSE |
Sep 04, 16:00
63.01
-0.07
(-0.11%)
After-Hours: 20:00
Inspire Medical Systems Research and Development Expense (Quarterly) : 24.70M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.70M |
| March 31, 2026 | 25.83M |
| December 31, 2025 | 24.94M |
| September 30, 2025 | 24.21M |
| June 30, 2025 | 26.21M |
| March 31, 2025 | 27.80M |
| December 31, 2024 | 30.34M |
| September 30, 2024 | 26.08M |
| June 30, 2024 | 28.86M |
| March 31, 2024 | 28.85M |
| December 31, 2023 | 31.05M |
| September 30, 2023 | 29.14M |
| June 30, 2023 | 30.82M |
| March 31, 2023 | 25.52M |
| December 31, 2022 | 21.25M |
| September 30, 2022 | 20.99M |
| June 30, 2022 | 14.53M |
| March 31, 2022 | 11.87M |
| December 31, 2021 | 10.29M |
| September 30, 2021 | 9.614M |
| June 30, 2021 | 9.288M |
| Date | Value |
|---|---|
| March 31, 2021 | 8.154M |
| December 31, 2020 | 7.285M |
| September 30, 2020 | 7.307M |
| June 30, 2020 | 6.062M |
| March 31, 2020 | 5.438M |
| December 31, 2019 | 3.767M |
| September 30, 2019 | 3.623M |
| June 30, 2019 | 2.846M |
| March 31, 2019 | 2.603M |
| December 31, 2018 | 2.152M |
| September 30, 2018 | 1.771M |
| June 30, 2018 | 1.735M |
| March 31, 2018 | 1.73M |
| December 31, 2017 | 1.683M |
| September 30, 2017 | 1.175M |
| June 30, 2017 | 1.743M |
| March 31, 2017 | 1.593M |
| December 31, 2016 | 1.858M |
| September 30, 2016 | 1.635M |
| June 30, 2016 | 1.899M |
| March 31, 2016 | 1.699M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 370.40M |
| Globus Medical, Inc. | 36.32M |
| Enovis Corp. | 31.69M |
| Inogen, Inc. | 5.871M |
| Solventum Corp. | 178.00M |